CAS 164656-23-9
:Dutasteride
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-Bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-1H-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,6aS,7S)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- (4aR,6aS,7S,9aS,9bS,11aR)-N-[2,5-bis(trifluoromethyl)phenyl]-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide
- (5Alpha,17Beta)-N-{2,5-Bis(Trifluoromethyl)Phenyl}-3-Oxo-4-Azaandrost-L-Ene-17-Carboxamide
- (5α,17β)-N-[(2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5-androst-1-ene-17-carboxamide
- 1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-
- 4-Azaandrost-1-ene-17-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-, (5α,17β)-
- Avodart
- Avolve
- Gg 745
- Gi 198745
- Veltride
- Vedi altri sinonimi
DUTASTERIDE FOR SYSTEM SUITABILITY CRS
CAS:DUTASTERIDE FOR SYSTEM SUITABILITY CRSFormula:C27H30F6N2O2Colore e forma:White To Slightly Yellow. Powder., White To Slightly Yellow. Powder.Peso molecolare:528.5297Dutasteride
CAS:Adrenal cortical hormones and their derivatives nesoiFormula:C27H30F6N2O2Colore e forma:White Pale Yellow PowderPeso molecolare:528.221151H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-
CAS:Formula:C27H30F6N2O2Purezza:98%Colore e forma:SolidPeso molecolare:528.5297Dutasteride
CAS:Dutasteride (GI 198745) is a 5-alpha-reductase inhibitor that inhibits both type-1 and type2 isoforms of the enzyme and is used to treat benign prostaticFormula:C27H30F6N2O2Purezza:99.58%Colore e forma:White Crystalline SolidPeso molecolare:528.53Ref: TM-T1499
5mg35,00€10mg54,00€25mg84,00€50mg100,00€100mg150,00€200mg203,00€500mg341,00€1mL*10mM (DMSO)54,00€Dutasteride
CAS:Formula:C27H30F6N2O2Purezza:≥ 98.0%Colore e forma:White to almost white crystalline powderPeso molecolare:528.53Dutasteride-13C6
CAS:Formula:C2113C6H30F6N2O2Colore e forma:White To Off-White SolidPeso molecolare:534.49Dutasteride
CAS:Formula:C27H30F6N2O2Purezza:>98.0%(HPLC)Colore e forma:White to Light yellow powder to crystalPeso molecolare:528.54Dutasteride Impurity 5
CAS:Formula:C27H31F6NO3Colore e forma:White To Off-White SolidPeso molecolare:531.54Ref: 4Z-D-3525
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaDutasteride
CAS:Prodotto controllatoApplications Dutasteride is a dual inhibitor of 5α-reductase isoenzymes type 1 and 2; structurally related to Finasteride (F342000). Dutasteride is used in the treatment of benign prostatic hyperplasia.
References Bakshi, R.K., et al.: J. Med. Chem., 38, 3189 (1995), Gisleskog, P.O., et al.: Brit. J. Clin. Pharmacol., 47, 53 (1999), Djavan, B., et al.: Expert Opin. Pharmacother., 6, 311 (2005),Formula:C27H30F6N2O2Colore e forma:NeatPeso molecolare:528.53Dutasteride - Bio-X ™
CAS:Dutasteride is an androgenic compound and a 5α-reductase inhibitor that is used to treat benign prostatic hyperplasia (BPH) and male pattern baldness. Dutasteride reduces prostate volume and improves symptoms of BPH by inhibiting the enzyme 5α-reductase, which converts testosterone to dihydrotestosterone.Formula:C27H30F6N2O2Purezza:(%) Min. 99%Colore e forma:PowderPeso molecolare:528.53 g/molDutasteride
CAS:A dual irreversible inhibitor of 5α-reductase isoforms 5AR1 and 5AR2 with IC50 of 6 nM and 7 nM, respectively. It supresses the production of dihydrotestosterone and has been used for the treatment of benign prostatic hyperplasia, alopecia and hirsutism in women with polycystic ovary syndrome. In rodent models for Parkinson’s disease, Dutasteride reduced L-DOPA-induced dyskinesia without altering the therapeutic effect of L-DOPA.
Formula:C27H30F6N2O2Purezza:Min. 98 Area-%Colore e forma:White PowderPeso molecolare:528.53 g/mol













